{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:13:46Z","timestamp":1791994426633,"version":"4.4.0"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,22]]},"abstract":"<jats:p>As selective PDE-4 small molecule inhibitor, Crisaborole has been used with success in atopic dermatitis and psoriasis. Here we report two vitiligo patients successfully treated with crisaborole ointment.<\/jats:p>","DOI":"10.1093\/bjd\/ljac092","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T14:19:47Z","timestamp":1674224387000},"page":"436-437","source":"Crossref","is-referenced-by-count":16,"title":["Successful treatment of vitiligo with crisaborole ointment: a report of two cases"],"prefix":"10.1093","volume":"188","author":[{"given":"Xiukun","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Dermatology, Hangzhou Third People's Hospital , Hangzhou , China"},{"name":"Department of Dermatology, Affiliated Hangzhou Dermatology Hospital of Zhejiang University School of Medicine , Hangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hangzhou Third People's Hospital , Hangzhou , China"},{"name":"Department of Dermatology, Affiliated Hangzhou Dermatology Hospital of Zhejiang University School of Medicine , Hangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-e","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hangzhou Third People's Hospital , Hangzhou , China"},{"name":"Department of Dermatology, Affiliated Hangzhou Dermatology Hospital of Zhejiang University School of Medicine , Hangzhou , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"2023100620081671400_ljac092-B1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bjd.20596","article-title":"British Association of Dermatologists guidelines for the management of people with vitiligo 2021","volume":"186","author":"Eleftheriadou","year":"2022","journal-title":"Br J Dermatol"},{"key":"2023100620081671400_ljac092-B2","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jaci.2019.06.047","article-title":"Crisaborole and atopic dermatitis skin biomarkers: an intrapatient randomized trial","volume":"144","author":"Bissonnette","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2023100620081671400_ljac092-B3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jaad.2019.06.1288","article-title":"Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: a double-blind, randomized, vehicle-controlled trial","volume":"82","author":"Hashim","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2023100620081671400_ljac092-B4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jdcr.2021.03.028","article-title":"Repigmentation in a patient with vitiligo on crisaborole 2% ointment","volume":"11","author":"Tam","year":"2021","journal-title":"JAAD Case Rep"},{"key":"2023100620081671400_ljac092-B5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1476-5381.2009.00559.x","article-title":"Apremilast, a cAMP phosphodiesterase 4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis","volume":"159","author":"Schafer","year":"2010","journal-title":"Br J Pharmacol"},{"key":"2023100620081671400_ljac092-B6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.autrev.2017.07.005","article-title":"Biomarkers of disease activity in vitiligo: a systematic review","volume":"16","author":"Speeckaert","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2023100620081671400_ljac092-B7","doi-asserted-by":"crossref","first-page":"e12923","DOI":"10.1111\/dth.12923","article-title":"Apremilast is effective in controlling the progression of adult vitiligo: a case series","volume":"32","author":"Majid","year":"2019","journal-title":"Dermatol Ther"},{"key":"2023100620081671400_ljac092-B8","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.jid.2019.11.031","article-title":"Apremilast in combination with narrowband UVB in the treatment of vitiligo: a 52-week monocentric prospective randomized placebo-controlled study","volume":"140","author":"Khemis","year":"2020","journal-title":"J Invest Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljac092\/48807112\/ljac092.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/188\/3\/436\/51918975\/ljac092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/188\/3\/436\/51918975\/ljac092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T20:13:39Z","timestamp":1696623219000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/188\/3\/436\/6841385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":8,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,11,23]]},"published-print":{"date-parts":[[2023,2,22]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljac092","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2022,11,23]]}}}